Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    "Congenital antithrombin deficiency"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed A Study of KW-3357 in Congenital Antithrombin Deficiency
Condition: Congenital Antithrombin Deficiency
Intervention: Drug: KW-3357

Indicates status has not been verified in more than two years